Wikidata

(Q44505338)

English

Effects of therapy using a helicase-primase inhibitor (HPI) in mice infected with deliberate mixtures of wild-type HSV-1 and an HPI-resistant UL5 mutant

scientific article published on 24 April 2010

In more languages

Statements

title
Effects of therapy using a helicase-primase inhibitor (HPI) in mice infected with deliberate mixtures of wild-type HSV-1 and an HPI-resistant UL5 mutant (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
20420855
retrieved
3 December 2017
author name string
Soumi Sukla
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
20420855
retrieved
3 December 2017
Alexander Birkmann
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
20420855
retrieved
3 December 2017
Peter Lischka
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
20420855
retrieved
3 December 2017
Helga Ruebsamen-Schaeff
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
20420855
retrieved
3 December 2017
Holger Zimmermann
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
20420855
retrieved
3 December 2017
Hugh J Field
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
20420855
retrieved
3 December 2017
publication date
24 April 2010
1 reference
stated in
Europe PubMed Central
PubMed ID
20420855
retrieved
3 December 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q44505338&oldid=2025930082"